melis / Shutterstock.com
The development of gene technologies is still at a relatively early stage, with patent applications coming from research institutes and universities as well as industry. Gareth Williams has crunched the numbers.
Since the end of the first era of genome sequencing with the conclusion of the human genome project, the challenge facing the life sciences industry has been to apply our understanding to practical applications.
Our growing knowledge of the human genome allows us to pinpoint a specific genetic variation in a specific patient, which can predict future disease, or identify sensitivity to certain drugs. We can also optimise genes and proteins for particular applications and swap and engineer protein domains to open up new uses.
While the markets for certain genomic technologies—such as for sequencing technology—are already showing levels of maturity others, such as synthetic biology, are only just starting out. We analysed patent filings over the last decade for sequencing technology, personalised medicine and synthetic biology to examine where innovation is coming from, where it’s going and what this can tell us about each technology’s markets (see Table 1).
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
gene patents; human genome project;